Schlesinger Clinical appoints Figueroa

Figueroa (pictured) joins the business from Icon, where she was director of business development, focused on managing global clinical trials in pre-clinical to phase four. Prior to that, she held positions at IQVIA and Thermo Fisher Scientific.

In her new role, she will partner with Schlesinger Clinical’s accounts to support their clinical data collection and project management objectives.

Rob Ramirez, executive vice-president, strategic development, Schlesinger Group, said: “The energy Erica brings, together with her significant client relationship experience and proven track record in clinical research, creates a perfect fit with our growth plans.”